ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ImpediMed Ltd
Accounts Receivables Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Accounts Receivables
AU$2.2m
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
17%
R
Respiri Ltd
ASX:RSH
Accounts Receivables
AU$253.1k
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
12%
C
Cyclopharm Ltd
ASX:CYC
Accounts Receivables
AU$4.8m
CAGR 3-Years
-1%
CAGR 5-Years
8%
CAGR 10-Years
4%
Cochlear Ltd
ASX:COH
Accounts Receivables
AU$490.7m
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
9%
Optiscan Imaging Ltd
ASX:OIL
Accounts Receivables
AU$1.6m
CAGR 3-Years
8%
CAGR 5-Years
30%
CAGR 10-Years
9%
EMvision Medical Devices Ltd
ASX:EMV
Accounts Receivables
AU$16.2k
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Accounts Receivables?
Accounts Receivables
2.2m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Accounts Receivables amounts to 2.2m AUD.

What is ImpediMed Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
17%

Over the last year, the Accounts Receivables growth was -16%. The average annual Accounts Receivables growth rates for ImpediMed Ltd have been -8% over the past three years , 12% over the past five years , and 17% over the past ten years .

Back to Top